CCDR: Vol. 46 No. 4-April 2020: Respiratory syncytial virus (RSV)
Download the current issue as a PDFPublished by: The Public Health Agency of Canada
Date published: April 2, 2020
ISSN: 1481-8531
Submit a manuscript
About CCDR
Browse
Table of contents
Research
Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada
A Killikelly, M Tunis, A House, C Quach, W Vaudry, D Moore
Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat
A Killikelly, A Shane, MW Yeung, M Tunis, C Bancej, A House, W Vaudry, D Moore, C Quach
Infographic
Summary of RSV vaccine product in late-stage development
Outbreak
Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018
Y Wei, K Wilkinson, R Rusk, K Kadkhoda, C Loeppky
Surveillance
Measles surveillance in Canada: 2018
C Coulby, F Reyes Domingo, J Hiebert, D MacDonald
Epidemiology study
Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016
T Hirama, N Sabur, P Derkach, J McNamee, H Song, T Marras, S Brode
Series
Motivational interviewing: A powerful tool to address vaccine hesitancy
A Gagneur
Update
Coronavirus disease (COVID-19): For health professionals
Search CCDR